InsiderTrades

Form 4 for JSPR Jasper Therapeutics, Inc.

Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-21 · accession 0001213900-22-014562 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-23 2022-03-21 JSPR Lis William See Remarks, Dir A - Grant $0.00 +90.0K 90.0K New $0
DM 2022-03-23 2022-03-21 JSPR Lis William See Remarks, Dir A - Grant $0.00 +197.5K 100.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Voting Common Stock 2022-03-21 A A 89,972 $0.00 89,972 D — — (F1) The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of June 24, 2022 and June 27, 2022, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
2 Derivative Stock Option (right to buy) 2022-03-21 A A 89,972 $0.00 89,972 D $3.54 · — to 2032-03-21 89,972 Voting Common Stock (F3) 1/4th of the shares subject to the option vested on March 21, 2022, and 1/4th of the shares subject to the option shall vest on each of March 24, 2022, September 24, 2022 and March 24, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
3 Derivative Stock Option (right to buy) 2022-03-21 A A 7,500 $0.00 7,500 D $3.54 · — to 2032-03-21 7,500 Voting Common Stock (F2) 1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
4 Derivative Stock Option (right to buy) 2022-03-21 A A 100,000 $0.00 100,000 D $3.54 · — to 2032-03-21 100,000 Voting Common Stock (F4) 1/12th of the shares subject to the option shall vest on April 15, 2022, and 1/12th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive